Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 44% · prior close shown (market closed)
Limited proprietary earnings coverage for JSPR yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 16d ago
JSPR's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on JSPR.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for Jasper Therapeutics, Inc. (JSPR) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
JSPR's AI investment thesis
Upgrade to Premium for JSPR's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$0.59
Market cap
$19.48M
Profitable
No
Net income
$-75.80M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for Jasper Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Jasper Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.